60
Participants
Start Date
May 31, 2004
Primary Completion Date
February 28, 2006
Study Completion Date
December 31, 2006
Å6 subcutaneous injection
Carilion Gynecologic Oncology Associates, Roanoke
Gynecologic-Oncology Research and Development, LLC, Greenville
Medical College of Georgia Dept. of OB/GYN, Saint Agusta
Florida Hospital Cancer Institute, Orlando
University of Alabama, Birmingham, Birmingham
Chattanooga GYN Oncology, Chattanooga
University of Louisville JG Brown Cancer Center, Louisville
OSU College of Medicine, Columbus
Gabrail Cancer Center, Canton
St. Vincent Gyn-Onc, Indianapolis
Northern Indiana Cancer Research Consortium, South Bend
Gynecologic Oncology, Hinsdale
Barnes Jewish Hospital, St Louis
Hematology & Oncology Specialists, New Orleans
University of Oklahoma College of Medicine, Oklahoma City
Brooke Army Medical Center, Fort Sam Houston
University of Colorado Cancer Center, Aurora
Desert Oasis Cancer Center, Casa Grande
USC Keck School of Medicine Women's and Childrens Hospital, Los Angeles
Scripps Cancer Center, San Diego
University of California Irvine Medical Center, Orange
California Oncology of the Central Valley, Fresno
UC Davis Health System, Sacramento
Tripler Army Medical Center, Honolulu
Ångstrom Pharmaceuticals
INDUSTRY